Bremer Bank National Association’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Bremer Bank National Association's AZN Position: Q3 2022 in Review
Bremer Bank National Association sold out of AstraZeneca (AZN) in Q3 2022, closing a stake of 1,934 shares — an estimated $255K sold.
Bremer Bank National Association first reported a position in AZN in Q1 2019 and held it in 6 quarters. The position peaked at $299K in Q3 2021. 966 funds tracked by Wall St. Rank hold AZN as of Q3 2022.
- Bremer Bank National Association reported no remaining AstraZeneca position as of Q3 2022 after selling out during the quarter.
- Bremer Bank National Association sold 1,934 AstraZeneca shares in Q3 2022, an estimated $255K.
- Bremer Bank National Association first reported a position in AstraZeneca in Q1 2019 and held it in 6 quarters.
- Bremer Bank National Association's AstraZeneca position peaked at $299K in Q3 2021.
- 966 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2022.
Based on Bremer Bank National Association's 13F filing for Q3 2022, filed 12 Oct 2022.